Literature DB >> 3355399

Neuropsychological performance in lateralized parkinsonism.

K B Spicer1, R J Roberts, P A LeWitt.   

Abstract

Seven dextral patients with Parkinson's disease (PD) who had predominant right-sided motor signs were compared on neuropsychological tests with eight dextral patients with PD who had predominant left-sided signs. Objective criteria for group designation were developed from clinical ratings. The patient subgroups were matched on age, education, estimated premorbid IQ, severity of motor signs, and medication usage. Patients with signs lateralized to the right were more impaired on tests of dominant hemisphere function (serial digit learning, confrontation naming, and verbal associative fluency), but no differences were found on tests of nondominant hemisphere function (form sequence learning, line orientation, facial recognition), indicating some correlation of neuropsychological performance with lateralization of predominant motor signs. Findings demonstrate that the cognitive deficits (particularly visuospatial) previously reported in the literature are not seen consistently in all subjects with PD.

Entities:  

Mesh:

Year:  1988        PMID: 3355399     DOI: 10.1001/archneur.1988.00520280079019

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

Review 1.  Cognitive differences between patients with left-sided and right-sided Parkinson's disease. A review.

Authors:  Nele Verreyt; Gudrun M S Nys; Patrick Santens; Guy Vingerhoets
Journal:  Neuropsychol Rev       Date:  2011-09-29       Impact factor: 7.444

2.  Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease.

Authors:  Thomas Holtgraves; Patrick McNamara; Kevin Cappaert; Raymond Durso
Journal:  Brain Cogn       Date:  2009-09-13       Impact factor: 2.310

3.  Cognitive functioning after pallidotomy for refractory Parkinson's disease.

Authors:  K Perrine; M Dogali; E Fazzini; D Sterio; E Kolodny; D Eidelberg; O Devinsky; A Beric
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

Review 4.  Neuropsychological aspects of Parkinson's disease.

Authors:  S A Raskin; J C Borod; J Tweedy
Journal:  Neuropsychol Rev       Date:  1990-09       Impact factor: 7.444

5.  Marked brain asymmetry with intact cognitive functioning in idiopathic Parkinson's disease: a longitudinal analysis.

Authors:  Jared J Tanner; Shellie-Anne Levy; Nadine A Schwab; Loren P Hizel; Peter T Nguyen; Michael S Okun; Catherine C Price
Journal:  Clin Neuropsychol       Date:  2016-11-04       Impact factor: 3.535

6.  Association between presenting motor symptoms and the risk of cognitive impairment in Parkinson's disease.

Authors:  M Viitanen; J A Mortimer; D D Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

7.  Unilateral deep brain stimulation surgery in Parkinson's disease improves ipsilateral symptoms regardless of laterality.

Authors:  Kamal Shemisa; Chris J Hass; Kelly D Foote; Michael S Okun; Samuel S Wu; Charles E Jacobson; Yunfeng Dai; Genko Oyama; Hubert H Fernandez
Journal:  Parkinsonism Relat Disord       Date:  2011-12       Impact factor: 4.891

8.  Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease.

Authors:  T Hershey; J Wu; P M Weaver; D C Perantie; M Karimi; S D Tabbal; J S Perlmutter
Journal:  Exp Neurol       Date:  2007-11-29       Impact factor: 5.330

9.  Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.

Authors:  A Agniel; P Celsis; G Viallard; J L Montastruc; O Rascol; J F Demonet; J P Marc-Vergnes; A Rascol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

10.  Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease.

Authors:  Erin R Foster; Kevin J Black; Jo Ann V Antenor-Dorsey; Joel S Perlmutter; Tamara Hershey
Journal:  Brain Cogn       Date:  2007-11-19       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.